{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:38:27Z","timestamp":1789180707438,"version":"build-2803163510"},"reference-count":38,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/03007995.2021.1940907","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T03:39:25Z","timestamp":1625456365000},"page":"1555-1561","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics, treatment patterns, healthcare resource use, and costs among pediatric patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas: a retrospective database analysis of a medicaid population"],"prefix":"10.1080","volume":"37","author":[{"given":"Xiaoqin","family":"Yang","sequence":"first","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Desai","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions, North Wales, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Mirchandani","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions, North Wales, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions, North Wales, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sarpong","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuvayu","family":"Sen","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.113"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-11"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/320121"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.465"},{"key":"e_1_3_6_7_1","unstructured":"Orphanet [Internet]. Neurofibromatosis type 1. New York (NY): Orphanet; 2014 [cited 2020 October 8]. Available from: https:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search.php?lng=EN&data_id=185&Disease_Disease_Search_diseaseGroup=Neurofibromatosis-type-1&Disease_Disease_Search_diseaseType=Pat&Disease(s)\/group%20of%20diseases=Neurofibromatosis-type-1&title=Neurofibromatosis%20type%201&search=Disease_Search_Simple"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.3.608"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2008-011"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.04.008"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100004017"},{"issue":"1","key":"e_1_3_6_14_1","first-page":"62","article-title":"Neurofibromatosis type 1: review and update on emerging therapies","volume":"8","author":"Karaconji T","year":"2019","unstructured":"Karaconji T, Whist E, Jamieson RV, et\u00a0al. Neurofibromatosis type 1: review and update on emerging therapies. Asia-Pacific Journal of Ophthalmology. 2019;8(1):62\u201372.","journal-title":"Asia-Pacific Journal of Ophthalmology"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.5.311"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-6-477"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.07.004"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/BPO.0b013e31820cad77"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.30"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000169"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.772979"},{"key":"e_1_3_6_22_1","unstructured":"US Food and Drug Administration [Internet]. FDA approves first therapy for children with debilitating and disfiguring rare disease. Silver Spring (MD): FDA; 2020 [cited 2021 June 30]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-therapy-children-debilitating-and-disfiguring-rare-disease"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy067"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37123"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsr124"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03543.x"},{"key":"e_1_3_6_27_1","unstructured":"IBM [Internet]. IBM MarketScan research databases. Armonk (NY): IBM; 2020 [cited 2020 January 29]. Available from: https:\/\/www.ibm.com\/products\/marketscan-research-databases"},{"key":"e_1_3_6_28_1","unstructured":"IBM [Internet]. Data brochure: research databases for life sciences researchers. Armonk (NY): IBM; 2019 [cited 2020 May 2]. Available from: https:\/\/www.ibm.com\/downloads\/cas\/OWZWJ0QO"},{"key":"e_1_3_6_29_1","unstructured":"Neurofibroma Midwest [Internet]. Insurance coverage for neurofibroma removal. Saint Charles (IL): Neurofibroma Midwest; 2015. [cited 2020 September 3]. Available from: https:\/\/www.nfmidwest.org\/wp-content\/uploads\/2016\/03\/Insurance-Coverage-of-Fibroma-Removal.pdf"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.01.425"},{"key":"e_1_3_6_31_1","unstructured":"Cancer Research Network [Internet]. Cancer therapy look-up tables. Kaiser Permanente Division of Research. 2020 [cited 2020 January 29]. Available from: http:\/\/www.hcsrn.org\/crn\/en\/RESEARCH\/LookupTables\/"},{"key":"e_1_3_6_32_1","unstructured":"US Bureau of Labor Statistics [Internet]. Consumer price index. 2020 [cited 2020 October 3]. Available from: https:\/\/www.bls.gov\/cpi\/home.htm"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bd1326"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.10.019"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37987"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.081"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.08.051"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S265690"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61069"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2021.1940907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T09:06:00Z","timestamp":1696842360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2021.1940907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/03007995.2021.1940907"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2021.1940907","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-98302\/v1","asserted-by":"object"}]},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}